Publications by authors named "Jamal A Alruwaili"

Article Synopsis
  • * A study explored 224 natural compounds from the COCONUT database, identifying four candidates with favorable docking scores for targeting MTase: CNP0307160, CNP0082902, CNP0449158, and CNP0296775, which showed strong interactions through virtual screening and re-docking analysis.
  • * Molecular dynamics simulations revealed that CNP0296775 exhibited the best structural stability and interaction with MTase, suggesting it as a promising inhibitor for
View Article and Find Full Text PDF

The monkeypox virus (MPXV) is an enveloped, double-stranded DNA virus belonging to the genus Orthopox viruses. In recent years, the virus has spread to countries where it was previously unknown, turning it into a worldwide emergency for public health. This study employs a structural-based drug design approach to identify potential inhibitors for the core cysteine proteinase of MPXV.

View Article and Find Full Text PDF

The unmet medical need for drug-resistant tuberculosis (DRTB) is a significant concern. Accordingly, identifying new drug targets for tuberculosis (TB) treatment and developing new therapies based on these drug targets is one of the strategies to tackle DRTB. QcrB is an innovative drug target to create treatments for DRTB.

View Article and Find Full Text PDF

Background: The emergence of various drug-resistant strains of Mycobacterium tuberculosis compelled medicinal chemists to expedite the discovery of novel, safer alternatives to present regimens. Decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1), an essential component of arabinogalactan biosynthesis, has been considered a novel target for developing new inhibitors against Tuberculosis. We aimed to discover DprE1 inhibitors utilizing the drug repurposing approach.

View Article and Find Full Text PDF

Background: The incidence of prostate cancer (PCa) has increased in recent years due to the aging of the population and increased testing; however, mortality rates have remained largely unchanged. Studies have shown deficiencies in predicting patient outcome for both of the major PCa diagnostic tools, namely prostate specific antigen (PSA) and transrectal ultrasound-guided biopsy. Therefore, serum biomarkers are needed that accurately predict prognosis of PCa (indolent vs.

View Article and Find Full Text PDF